“With confinis, we welcome a deeply experienced team and a company whose expertise and entrepreneurial culture align perfectly with our ambition to build a science-driven, pan-European leader in Life Sciences services,” said Giuseppe Pileggi, CEO of athagoras.

“This step marks both a continuation and a new beginning,” said Dr. Andrea Biasiucci, CEO of confinis. “We’ve shaped confinis into a resilient, mission-focused, AI-native organization. Now, alongside our peers at athagoras we’re positioned to offer clients broader, deeper support, without compromising on the quality and independence they’ve come to expect.”

The acquisition enhances athagoras’ ability to provide a fully integrated regulatory and compliance ecosystem, advancing its long-term vision to become the partner of choice for Life Sciences companies navigating complex global regulatory environments.

The post athagoras acquires confinis ag to strengthen Regulatory Capabilities in the Life Sciences Sector appeared first on athagoras.

Founded in 1992 by Dr. Johannes Kremer, DiaMed has long been a trusted partner for pharmaceutical companies seeking reliable guidance in both regulatory and post-marketing activities.

“Joining athagoras marks an exciting new chapter for DiaMed,” said Dr. Johannes Kremer, Founder and CEO of DiaMed. “We’re proud to bring our practical experience and customer commitment into a wider European network. Together with our new colleagues, we’ll enhance what we do best, supporting clients with tailor-made solutions that ensure compliance and safety.”

This acquisition reinforces athagoras’ commitment to supporting the development of safe and effective medicines while maintaining close proximity to local and regional clients. With strong teams already operating in Germany, the UK, and across Europe, athagoras connects specialist expertise with data-driven processes, creating a platform that empowers clients to navigate regulatory complexity with confidence.

The post athagoras strengthens Regulatory Affairs and Pharmacovigilance expertise with the acquisition of DiaMed appeared first on athagoras.

About the IGES Group

The IGES Group is a network of research and consulting companies in Europe specialising in the field of healthcare. The core of the group is the IGES Institute, founded in 1980, which works on issues relating to European healthcare systems and is now one of the largest private-sector companies in this field in Germany. In addition, the Group has several specialist subsidiaries in seven European countries that provide services to the international Life Science industries. The IGES Group has a workforce of more than 200 highly qualified individuals. 

About athagoras

athagoras is building up a group of leading service providers to create a technology-enabled European specialist service provider for healthcare systems and for the clinical and commercial development of healthcare innovations in the pharmaceutical, biotech and medtech industries in the areas of regulatory affairs, pharmacovigilance, market access and real-world evidence.

The post IGES group continues internationalization and joins the athagoras group appeared first on athagoras.

“We are thrilled to be joining the athagoras group at this exciting time” said Mark Lipscombe, Managing Director of S-cubed Ltd “this will allow us to expand the range of services that we currently offer to our clients, whilst creating new opportunities to increase our European and Global reach as part of the wider athagoras team.”

S-cubed Biometrics Ltd, a data management and statistics services company, will continue to operate independently.

athagoras Holding GmbH is building a group of leading service providers to create a tech-enabled European specialist service provider for the clinical and commercial development of healthcare innovations in the pharmaceutical & biotech industry within regulatory affairs, pharmacovigilance, as well as market access and real-world evidence. For more information, please visit the about us page.

Dr. Roman-Marcus Rittweger, CEO of athagoras, stated: “We are extremely pleased to welcome S-cubed Ltd into our family of portfolio companies. The addition of this well known and successful regulatory affairs and QA provider will provide athagoras with a key element as one of our core strategic pillars. We welcome the S-cubed team to the athagoras family and look forward to working together to provide expanded regulatory and quality support to our clients.”

The post S-cubed Ltd is excited to announce that it has joined the athagoras group appeared first on athagoras.

Strategic Rationale

The acquisition combines Quantify’s Nordic market leadership with athagoras’ strategy, creating a stronger platform to serve clients worldwide. In particular, the U.S. market’s demand for high-quality RWE and value demonstration continues to grow. athagoras will leverage its expanded capabilities to drive innovation and value across its portfolio.

Dr. Roman-Marcus Rittweger, CEO of athagoras, stated: “The acquisition of Quantify Research marks a significant step in our strategy to build a leading global Life Sciences consulting group. Quantify’s expertise in real-world evidence and market access complements our existing capabilities, enhancing our ability to support the Life Science industry and navigate the complex access landscape. We welcome the Quantify team to the athagoras family as we work together to shape the future of market access.”

“This partnership accelerates our international expansion and strengthens our ability to deliver comprehensive real-world evidence and market access solutions to clients,” said Dr. Kirk Geale, CEO of Quantify Research. “By joining forces with athagoras, we can leverage our unique Nordic data assets and market access expertise across a global platform, creating new opportunities for Life Sciences companies worldwide and continuing our mission to enable patient-centric healthcare.”

Future Outlook

athagoras will drive growth and innovation by expanding the scope of Quantify’s unique evidence solutions and creating synergies across its current and future portfolio companies. This acquisition strengthens athagoras’ progress towards becoming the European leader in life science consulting, offering unparalleled expertise and data-driven insights to Life Sciences companies worldwide. The expanded platform is well positioned for future growth and the delivery of innovative solutions that drive value for clients.

The post athagoras acquires Quantify Research to enhance real-world evidence and market access capabilities appeared first on athagoras.

“We are excited to embark on this next phase of the CSO journey with athagoras,” said Dr. Silke Ostermann, CEO of CSO Pharma Consulting. “We believe this partnership will lead to long-term innovation and strengthen our ability to contribute to patients’ health all over the world.” For CSO clients, the partnership with athagoras provides more comprehensive solutions and increased service efficiency. Clients will continue to enjoy seamless support with further opportunities. CSO remains dedicated to its trusted reputation and reliable internal structure, ensuring continuity for both clients and employees.

“We are thrilled to welcome CSO into the athagoras family,” said Roman Rittweger, CEO of athagoras group. “Their deep industry knowledge and commitment to excellence and innovation perfectly complement our strategic goals. Together, we will deliver unparalleled value to our clients.”

The acquisition is a testament to athagoras group’s commitment to purposeful growth. As we continue to expand our footprint, we remain dedicated to delivering high-quality, tech-enabled services that meet the dynamic needs of our clients.

The post CSO Pharma Consulting GmbH joins athagoras group to enlarge and internationalize pharmacovigilance and development services for the pharma and healthcare sectors appeared first on athagoras.

The post Greenpeak Partners supports strategic collaboration between athagoras and MIGx to enhance tech-enabled services for the pharma and biotech sectors appeared first on athagoras.